National Transgender HIV Testing Day
National Transgender HIV Testing Day (NTHTD) is observed each year on April 18 and recognizes the importance of routine HIV testing, status awareness, and continued focus on HIV prevention and treatment efforts in people who are transgender or gender nonbinary. NTHTD was established by the Centers of Disease Control and Prevention (CDC) and the University of San Francisco Transgender Center of Excellence.
According to the CDC, in 2018 adult and adolescent transgender people comprise 2% of new HIV diagnoses in the U.S. People who are transgender or gender nonbinary may face challenges that can impact their likelihood to engage in HIV prevention and treatment, such as HIV stigma and transphobic discrimination.
To learn more, browse this NTHTD webpage.
The U.S. Government recognizes National Transgender HIV Testing Day.
National Transgender HIV Testing Day Webpages
NIH Research Related to HIV and AIDS in Transgender and Nonbinary People
- NIH Strategic Plan for HIV and HIV-Related Research (FY 2021—2025). Developed by the National Institutes of Health (NIH) Office of AIDS Research (OAR), the plan describes NIH research priorities to prevent, treat, and eventually cure HIV and AIDS. Key NIH research areas include investigating factors influencing inequalities in HIV testing, engagement, and health outcomes and strategies to mitigate HIV-associated stigma and discrimination.
- Clinical Trials Related to HIV and AIDS and Transgender People: Research studies related to HIV and AIDS and transgender people, from ClinicaTrials.gov. Call ClinicalInfo at 1-800-448-0440 for assistance with your clinical trial search.
Recent Research Related to HIV and AIDS in Transgender and Nonbinary People
- From PubMed.gov